Efficiency and transparency of clinical drug trials must improve The efficiency and transparency of clinical drug trials in the Netherlands must improve. That concludes Sander van den Bogert in his PhD thesis ‘Trials & Tribulations.
ICP M&M meetings in 2013 The 23rd CCE Workshop and 29th Task Force Meeting of the ICP M&M will be held 8-11 April 2013 in Copenhagen, Denmark.
Call for data on "no net loss of biodiversity" The CCE is pleased to publicate an announcement and a detailed substantiation and technical description of the call for data on “no net loss of biodiversity” which has been adopted at the 31st meet